Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oragenics Inc. (OGEN)

1.03   0.06 (6.19%) 07-10 16:00
Open: 1.15 Pre. Close: 0.97
High: 1.32 Low: 1
Volume: 66,722,619 Market Cap: 57M
Oragenics, Inc. develops novel antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring compound for use in weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against dental caries, or tooth decay. Oragenics, Inc. has collaboration agreements with Precigen, Inc. and its subsidiary, Intrexon Actobiotics NV to develop AG013; and a license agreement with LPThera LLC to develop LPT3-04. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.322 - 1.327 1.327 - 1.33
Low: 0.99 - 0.995 0.995 - 0.998
Close: 1.023 - 1.03 1.03 - 1.036

Technical analysis

as of: 2020-07-10 4:30:51 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.54     One year: 1.80
Support: Support1: 0.81    Support2: 0.50
Resistance: Resistance1: 1.32    Resistance2: 1.54
Pivot: 0.70
Moving Average: MA(5): 0.87     MA(20): 0.66
MA(100): 0.58     MA(250): 0.52
MACD: MACD(12,26): 0.09     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 69.83     %D(3): 69.53
RSI: RSI(14): 80.73
52-week: High: 1.32  Low: 0.35  Change(%): 114.6
Average Vol(K): 3-Month: 527816  10-Days: 1667218

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
OGEN has closed It is unclear right now based on current numbers. 155% wider than normal. The large width of the bands suggest high volatility as compared to OGEN's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 10 Jul 2020
Oragenics Inc. Pushes to $1.24 after OGEN Updates on COVID-19 Vaccine - Frisco Herald

Fri, 10 Jul 2020
Oragenics Targets Human Trials On Covid-19 Vaccine By Early 2021; Stops Trial On Oral Mucositis - Nasdaq

Fri, 10 Jul 2020
Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program - Business Wire

Thu, 09 Jul 2020
Is Oragenics Inc (OGEN) Stock a Good Buy? - InvestorsObserver

Wed, 08 Jul 2020
Why Oragenics, Inc. (OGEN) Is in Such Horrid Condition: Rise 2.65% - The News Heater

Tue, 07 Jul 2020
Do Oragenics Inc. (OGEN) beta value of 0.51 signposts another twist? - The InvestChronicle

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 55
Shares Float (M) 35
% Held by Insiders 4.96
% Held by Institutions 19.36
Shares Short (K) 858
Shares Short P. Month (K) 1,310

Stock Financials

EPS -0.377
EPS Est This Year -0.180
EPS Est Next Year -0.230
Book Value (p.s.) 0.120
Profit Margin
Operating Margin
Return on Assets (ttm) -47.3
Return on Equity (ttm) -82.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.319
Qtrly Earnings Growth
Operating Cash Flow (M) -15
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -2.73
PEG Ratio
Price to Book value 8.58
Price to Sales
Price to Cash Flow -3.90

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.